These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8001682)

  • 21. Oxidatively fragmented phospholipids as inflammatory mediators: the dark side of polyunsaturated lipids.
    Zimmerman GA; Prescott SM; McIntyre TM
    J Nutr; 1995 Jun; 125(6 Suppl):1661S-1665S. PubMed ID: 7782922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Minimal oxidation and storage of low density lipoproteins result in an increased susceptibility to phospholipid hydrolysis by phospholipase A2.
    Eckey R; Menschikowski M; Lattke P; Jaross W
    Atherosclerosis; 1997 Jul; 132(2):165-76. PubMed ID: 9242962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human plasma platelet-activating factor acetylhydrolase. Oxidatively fragmented phospholipids as substrates.
    Stremler KE; Stafforini DM; Prescott SM; McIntyre TM
    J Biol Chem; 1991 Jun; 266(17):11095-103. PubMed ID: 2040620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phagocytic activation induces formation of platelet-activating factor in human monocyte-derived macrophages and in macrophage-derived foam cells. Relevance to the inflammatory reaction in atherogenesis.
    Dentan C; Lesnik P; Chapman MJ; Ninio E
    Eur J Biochem; 1996 Feb; 236(1):48-55. PubMed ID: 8617285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxidized LDL contains inflammatory PAF-like phospholipids.
    Marathe GK; Prescott SM; Zimmerman GA; McIntyre TM
    Trends Cardiovasc Med; 2001; 11(3-4):139-42. PubMed ID: 11686003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determinants of bioactivity of oxidized phospholipids. Specific oxidized fatty acyl groups at the sn-2 position.
    Subbanagounder G; Leitinger N; Schwenke DC; Wong JW; Lee H; Rizza C; Watson AD; Faull KF; Fogelman AM; Berliner JA
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2248-54. PubMed ID: 11031211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesions.
    Häkkinen T; Luoma JS; Hiltunen MO; Macphee CH; Milliner KJ; Patel L; Rice SQ; Tew DG; Karkola K; Ylä-Herttuala S
    Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2909-17. PubMed ID: 10591668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergism between platelet-activating factor-like phospholipids and peroxisome proliferator-activated receptor gamma agonists generated during low density lipoprotein oxidation that induces lipid body formation in leukocytes.
    de Assis EF; Silva AR; Caiado LF; Marathe GK; Zimmerman GA; Prescott SM; McIntyre TM; Bozza PT; de Castro-Faria-Neto HC
    J Immunol; 2003 Aug; 171(4):2090-8. PubMed ID: 12902515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydrolysis of platelet activating factor and its methylated analogs by acetylhydrolases.
    Yanoshita R; Kudo I; Ikizawa K; Chang HW; Kobayashi S; Ohno M; Nojima S; Inoue K
    J Biochem; 1988 May; 103(5):815-9. PubMed ID: 3182751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel reversible, irreversible and fluorescent inhibitors of platelet-activating factor acetylhydrolase as mechanistic probes.
    Deigner HP; Kinscherf R; Claus R; Fyrnys B; Blencowe C; Hermetter A
    Atherosclerosis; 1999 May; 144(1):79-90. PubMed ID: 10381281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenovirus-mediated gene transfer of Lp-PLA2 reduces LDL degradation and foam cell formation in vitro.
    Turunen P; Jalkanen J; Heikura T; Puhakka H; Karppi J; Nyyssönen K; Ylä-Herttuala S
    J Lipid Res; 2004 Sep; 45(9):1633-9. PubMed ID: 15231855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of antiphospholipid antibody recognition with the structure of synthetic oxidized phospholipids. Importance of Schiff base formation and aldol condensation.
    Friedman P; Horkko S; Steinberg D; Witztum JL; Dennis EA
    J Biol Chem; 2002 Mar; 277(9):7010-20. PubMed ID: 11744722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biosynthesis of paf-acether. XIV. Paf-acether output in murine peritoneal macrophages is regulated by the level of acetylhydrolase.
    Palmantier R; Dulioust A; Maiza H; Benveniste J; Ninio E
    Biochem Biophys Res Commun; 1989 Jul; 162(1):475-82. PubMed ID: 2751666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipid peroxidation in low density lipoproteins from human plasma and egg yolk promotes accumulation of 1-acyl analogues of platelet-activating factor-like lipids.
    Tokumura A; Toujima M; Yoshioka Y; Fukuzawa K
    Lipids; 1996 Dec; 31(12):1251-8. PubMed ID: 8972457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of platelet activating factor on the kinetics of LDL oxidation in vitro.
    Deigner HP; Dresel HA
    FEBS Lett; 1993 Feb; 317(3):202-6. PubMed ID: 8425606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial hypercholesterolaemia and platelet-activating factor acetylhydrolase: difference between the homozygous and heterozygous form.
    Napoli C
    Eur J Clin Invest; 1998 Jun; 28(6):506-9. PubMed ID: 9693945
    [No Abstract]   [Full Text] [Related]  

  • 37. 1 Acyl-2 acetyl-sn-glycero-3 phosphocholine decreases the susceptibility of low-density lipoprotein to oxidative modification by copper ions, monocytes or endothelial cells.
    Maziere C; Djavahery-Mergny M; Auclair M; Maziere JC
    Biochim Biophys Acta; 1994 Jan; 1210(2):233-8. PubMed ID: 8280775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytosolic phospholipase A2 mediates arachidonoyl phospholipid hydrolysis in immortalized rat brain endothelial cells stimulated by oxidized LDL.
    Lupo G; Assero G; Anfuso CD; Nicotra A; Palumbo M; Cannavò G; Renis M; Ragusa N; Alberghina M
    Biochim Biophys Acta; 2002 Nov; 1585(1):19-29. PubMed ID: 12457711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impairment of endothelium-dependent aorta relaxation by phospholipid components of oxidized low-density lipoprotein.
    Vasques E; Almeida AL; Noya V; D'Alegria B; Marathe G; McIntyre TM; Tibiriçá E; Bozza PT; Silva AR; Castro-Faria-Neto HC
    Endothelium; 2006; 13(1):1-8. PubMed ID: 16885061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells.
    Heery JM; Kozak M; Stafforini DM; Jones DA; Zimmerman GA; McIntyre TM; Prescott SM
    J Clin Invest; 1995 Nov; 96(5):2322-30. PubMed ID: 7593619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.